Skip to main content
Past Event Sticker

PfP – NCD Pacing Event: ADE Leadership Buy-in: Anticoagulants and Opioids

Diverse Business Group Business Audience
Top

Thursday, January 18, 2018, 10:00 a.m. to 11:00 a.m. PT.

 Gaining Buy-in for Preventing Adverse Drug Events Related to Anticoagulants and Opioids

Summary from 1/18 Pacing Event: “Gaining Buy-in for Preventing Adverse Drug Events Related to Anticoagulants and Opioids”

This session was the second in a two-part Pacing Event series, which began on January 11th, to focus on a commonly-reported barrier to progress on adverse drug events (ADEs) by HIINs: hospital-level leadership buy-in. To address this barrier, this two-part webinar series featured national-level subject matter experts and thought leaders who provided information about the prevalence of and cost associated with ADEs, and then shared ideas for driving improvements, including the need for measures that are meaningful to hospital and physician leaders as a vehicle for gaining support and resources.

The session focused specifically on ADEs associated with anticoagulants and opioids with presentations from:

  • Nadine Shehab, PharmD, MPH, from the CDC’s Medication Safety Program, who framed the session by revisiting data that highlight the prevalence of ADEs and their cost to hospitals, as well as discussed the challenges that hospitals face in measuring and reporting ADEs;
  • Scott Kaatz, DO, MSc, FACP, SFHM, Medical Director for Professional Development and Research in the Division of Hospital Medicine and Senior Staff Hospitalist, at the Henry Ford Health System (Michigan HIIN), who focused on ADEs associated with anticoagulant use, particularly their importance and preventability as well as considerations regarding the meaningful measurement of this ADE; and
  • Paul Conlon, PharmD, JD, Senior Vice President Chief for Clinical Quality and Patient Safety at Trinity Health (Michigan HIIN), who focused on opioid-related ADEs by discussing the impact of the opioid epidemic on hospitals, as well as prevention of these ADEs and recommendations related to meaningful measures.

To view and download slides and recording from this Pacing Event, click here. To view and download slides and recording from part 1 of this Pacing Event series, “Gaining Buy-In for Preventing ADEs Related to Hypoglycemic Agents,” click here

Resources from 1/18 Pacing Event, “Gaining Buy-in for Preventing Adverse Drug Events Related to Anticoagulants and Opioids”

During last week’s 1/18 Pacing Event, Drs. Nadine Shehab (CDC), Scott Kaatz (Henry Ford Health System), and Paul Conlon (Trinity Health) shared and referenced a number of resources to assist that may be helpful in securing hospital leaders’ buy-in for preventing ADEs related to anticoagulants and opioids, as well as accessing best practices in prevention efforts. Many of the resources are available in the Pacing Event slides (slides and recording available here). Below please find a few resources to which we would like to draw your attention and/or add to those available in the slides:

Resources related to the impact of ADEs in general

  • HHS Office of Inspector General, 2010:  “Adverse Events in Hospitals: National Incidence Among Medicare Beneficiaries” (Click here)
  • Shehab, N., et al. US Emergency Department visits from adverse drug events, 2013-2014. JAMA 2016;316:2115-25. (Click here)

Resources related to Anticoagulation

  • IPRO’s “Management of Anticoagulation in the Peri-Procedural Period” app (plus other useful links) (Click here)
  • National Blood Clot Alliance Resources (Click here)
  • Anticoagulation Forum (Click here)
    • Open access publications (Click here

Resources related to Opioids

  • Weiss AJ, Elixhauser A, Barrett ML, et al. Opioid-related inpatient stays and Emergency Department visits by state, 2009-2014. HCUP Statistical Brief #219. December 2016. Agency for Healthcare Research and Quality, Rockville, MD. (Click here)
  • Pharmacy Quality Alliance Measures (Click here)
Audience/State: